Tumour characteristics and survivorship in a cohort of breast cancer: the MCC-Spain study

Purpose: The objective of this study is to analyse the relative survival with breast cancer in women diagnosed after new treatments were generalised and to ascertain the current effect that tumour characteristics such as grade, stage or subtype have on survival as well as the new AJCC-pathological p...

Full description

Bibliographic Details
Authors: Gómez-Acebo, Inés; Dierssen-Sotos, Trinidad; Palazuelos-Calderón, Camilo; Perez-Gomez, Beatriz; Amiano, Pilar; Guevara, Marcela; Molina, Antonio J; Domingo, Laia; Fernández-Ortiz, María; Moreno, Victor; Alguacil, Juan; Fernández-Tardón, Guillermo; Ibáñez, Josefa; Marcos-Gragera, Rafael; Diaz-Santos, Marian; Alonso, María Henar; Alonso-Molero, Jéssica; Castaño-Vinyals, Gemma; Palomo, Andrés García; Ardanaz, Eva; Molinuevo, Amaia; Aragones, Nuria; Kogevinas, Manolis; Pollan-Santamaria, Marina; Llorca, Javier
Format: Article
Publication date:2020
Country:España
Institution:Instituto de Salud Carlos III (ISCIII)
Repository:Repisalud
Language:English
OAI Identifier:oai:repisalud.isciii.es:20.500.12105/14109
Online Access:http://hdl.handle.net/20.500.12105/14109
Access Level:Open access
Keyword:Survivorship
Adult
Aged
_version_ 1878730561930919936
author Gómez-Acebo, Inés
author2 Dierssen-Sotos, Trinidad
Palazuelos-Calderón, Camilo
Perez-Gomez, Beatriz
Amiano, Pilar
Guevara, Marcela
Molina, Antonio J
Domingo, Laia
Fernández-Ortiz, María
Moreno, Victor
Alguacil, Juan
Fernández-Tardón, Guillermo
Ibáñez, Josefa
Marcos-Gragera, Rafael
Diaz-Santos, Marian
Alonso, María Henar
Alonso-Molero, Jéssica
Castaño-Vinyals, Gemma
Palomo, Andrés García
Ardanaz, Eva
Molinuevo, Amaia
Aragones, Nuria
Kogevinas, Manolis
Pollan-Santamaria, Marina
Llorca, Javier
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author_browse Alguacil, Juan
Alonso, María Henar
Alonso-Molero, Jéssica
Amiano, Pilar
Aragones, Nuria
Ardanaz, Eva
Castaño-Vinyals, Gemma
Diaz-Santos, Marian
Dierssen-Sotos, Trinidad
Domingo, Laia
Fernández-Ortiz, María
Fernández-Tardón, Guillermo
Guevara, Marcela
Gómez-Acebo, Inés
Ibáñez, Josefa
Kogevinas, Manolis
Llorca, Javier
Marcos-Gragera, Rafael
Molina, Antonio J
Molinuevo, Amaia
Moreno, Victor
Palazuelos-Calderón, Camilo
Palomo, Andrés García
Perez-Gomez, Beatriz
Pollan-Santamaria, Marina
author_facet Gómez-Acebo, Inés
Dierssen-Sotos, Trinidad
Palazuelos-Calderón, Camilo
Perez-Gomez, Beatriz
Amiano, Pilar
Guevara, Marcela
Molina, Antonio J
Domingo, Laia
Fernández-Ortiz, María
Moreno, Victor
Alguacil, Juan
Fernández-Tardón, Guillermo
Ibáñez, Josefa
Marcos-Gragera, Rafael
Diaz-Santos, Marian
Alonso, María Henar
Alonso-Molero, Jéssica
Castaño-Vinyals, Gemma
Palomo, Andrés García
Ardanaz, Eva
Molinuevo, Amaia
Aragones, Nuria
Kogevinas, Manolis
Pollan-Santamaria, Marina
Llorca, Javier
author_role author
collection Repisalud
description Purpose: The objective of this study is to analyse the relative survival with breast cancer in women diagnosed after new treatments were generalised and to ascertain the current effect that tumour characteristics such as grade, stage or subtype have on survival as well as the new AJCC-pathological prognostic score. Methods: The breast cancer MCC-Spain follow-up study is a prospective cohort study of 1685 incident breast cancer cases. Women between 20 and 85 years old were recruited between the years 2008 and 2013 in 18 hospitals located in 10 Spanish provinces and they have been followed until 2017/2018. Relative survival was estimated after 3, 5 and 8 years of follow-up using Ederer II method. In addition, Weibull regression adjusted by age, hospital, grade and stage was used to investigate prognosis factors. Results: Among components of TNM staging system, tumour size greater than 50 mm (i.e. T3 or T4) more than doubled the risk of dying, while N3 nodal involvement and presence of metastasis had a huge effect on mortality. The AJCC pathological prognostic score strongly correlated with survival; thus, hazard ratios increased as the score rose, being 2.31, 4.00, 4.94, 7.92, 2.26, 14.9 and 58.9 for scores IB, IIA, IIB, IIIA, IIIB, IIIC and IV, respectively. Conclusion: Both TNM staging and histological/molecular biomarkers are associated with overall survival in Spanish women with breast cancer; when both are combined in the AJCC pathological prognosis score, the prognostic value improved with risk indices that increased rapidly as the pathological prognosis score increased.
eu_rights_str_mv openAccess
format article
id ES_1ecdff7df44a2db97aacbf64ff1373be
institution Instituto de Salud Carlos III (ISCIII)
instname_str Instituto de Salud Carlos III (ISCIII)
language eng
network_acronym_str ES
network_name_str España
oai_identifier_str oai:repisalud.isciii.es:20.500.12105/14109
publishDate 2020
publishDateSort 2020
publisher Springer
publisherStr Springer
reponame_str Repisalud
spelling Tumour characteristics and survivorship in a cohort of breast cancer: the MCC-Spain study Gómez-Acebo, Inés Dierssen-Sotos, Trinidad Palazuelos-Calderón, Camilo Perez-Gomez, Beatriz Amiano, Pilar Guevara, Marcela Molina, Antonio J Domingo, Laia Fernández-Ortiz, María Moreno, Victor Alguacil, Juan Fernández-Tardón, Guillermo Ibáñez, Josefa Marcos-Gragera, Rafael Diaz-Santos, Marian Alonso, María Henar Alonso-Molero, Jéssica Castaño-Vinyals, Gemma Palomo, Andrés García Ardanaz, Eva Molinuevo, Amaia Aragones, Nuria Kogevinas, Manolis Pollan-Santamaria, Marina Llorca, Javier Survivorship Adult Aged Purpose: The objective of this study is to analyse the relative survival with breast cancer in women diagnosed after new treatments were generalised and to ascertain the current effect that tumour characteristics such as grade, stage or subtype have on survival as well as the new AJCC-pathological prognostic score. Methods: The breast cancer MCC-Spain follow-up study is a prospective cohort study of 1685 incident breast cancer cases. Women between 20 and 85 years old were recruited between the years 2008 and 2013 in 18 hospitals located in 10 Spanish provinces and they have been followed until 2017/2018. Relative survival was estimated after 3, 5 and 8 years of follow-up using Ederer II method. In addition, Weibull regression adjusted by age, hospital, grade and stage was used to investigate prognosis factors. Results: Among components of TNM staging system, tumour size greater than 50 mm (i.e. T3 or T4) more than doubled the risk of dying, while N3 nodal involvement and presence of metastasis had a huge effect on mortality. The AJCC pathological prognostic score strongly correlated with survival; thus, hazard ratios increased as the score rose, being 2.31, 4.00, 4.94, 7.92, 2.26, 14.9 and 58.9 for scores IB, IIA, IIB, IIIA, IIIB, IIIC and IV, respectively. Conclusion: Both TNM staging and histological/molecular biomarkers are associated with overall survival in Spanish women with breast cancer; when both are combined in the AJCC pathological prognosis score, the prognostic value improved with risk indices that increased rapidly as the pathological prognosis score increased. Springer http://hdl.handle.net/20.500.12105/14109
spellingShingle Tumour characteristics and survivorship in a cohort of breast cancer: the MCC-Spain study
Gómez-Acebo, Inés
Survivorship
Adult
Aged
title Tumour characteristics and survivorship in a cohort of breast cancer: the MCC-Spain study
title_full Tumour characteristics and survivorship in a cohort of breast cancer: the MCC-Spain study
title_fullStr Tumour characteristics and survivorship in a cohort of breast cancer: the MCC-Spain study
title_full_unstemmed Tumour characteristics and survivorship in a cohort of breast cancer: the MCC-Spain study
title_short Tumour characteristics and survivorship in a cohort of breast cancer: the MCC-Spain study
title_sort Tumour characteristics and survivorship in a cohort of breast cancer: the MCC-Spain study
topic Survivorship
Adult
Aged
topic_facet Survivorship
Adult
Aged
url http://hdl.handle.net/20.500.12105/14109